The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1427
Subscribers: Log in to read full issue.  Not a subscriber?  Subscribe or purchase issue.
Deep Brain Stimulation for Parkinson's Disease with Early Motor Complications

Deep brain stimulation is FDA-approved and has been used for years to treat patients with advanced Parkinson's disease (PD) who have severe levodopa-induced motor complications.1 New evidence from a controlled trial suggests that it may also be effective for patients with PD and early motor complications.

SURGICAL TREATMENT — Medical therapy is effective for initial treatment of PD.2 Surgical ablation or deep brain stimulation has generally been recommended only for patients with intolerable dyskinesias or motor fluctuations while on levodopa. Appropriate candidates for surgery are those whose cognition is relatively intact, who are not depressed, and who have no medical contraindications.3

DEEP BRAIN STIMULATION — High-frequency electrical stimulation of the subthalamic nucleus or ... more      

The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this issue?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this issue:
Title: Issue 1427
 Downloadable, electronic issue - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.
Recommend to your librarian